Transgender Use of Cigarettes, Cigars, and E-Cigarettes in a National Study
Transgender Use of Cigarettes, Cigars, and E-Cigarettes in a National Study
复制标题
DOI：
10.1016/j.amepre.2016.11.022
复制
发表时间：
2017-07-01
影响因子：
5.5
通讯作者：
Emery, Sherry
中科院分区：
文献类型：
--
作者：
Buchting, Francisco O.;Emory, Kristen T.;Emery, Sherry
简介：跨性别成年人的烟草使用仍然是一个研究领域，但报告的结果很少。有限的文献表明，与一般人群相比，跨性别成年人的吸烟率更高。这项全国性研究首次通过检查跨性别者烟草使用与性取向无关的差异来报告香烟、雪茄和电子烟。方法：通过对美国成年人（顺性别，n = 17,164；跨性别，n = 168）进行的全国横断面在线调查于 2013 年收集数据，并于 2015 年进行分析。过去 30 天的烟草使用点估计和调整逻辑回归，同时控制错误结果：跨性别成年人报告过去 30 天使用任何香烟/雪茄/电子烟产品（39.7% vs 25.1%）以及当前使用香烟（35.5% vs 20.7%）、雪茄（26.8% vs 9.3%）和电子烟（21.3% vs 5.0%）的比例高于顺性别成年人（所有 p 值 r0.003）。跨性别受访者在过去 30 天使用烟草产品的几率显着更高5.59）和香烟（OR = 2.10，95% CI = 1.35，3.28）与顺性别受访者（所有 p 值
Introduction: Tobacco use among transgender adults continues to be an area of research with few reported findings. The limited literature indicates higher cigarette use among transgender adults, compared with the general population. This national study is the first to report on cigarettes, cigars, and e-cigarettes by examining differences in transgender tobacco use independent of sexual orientation.Methods: Data were collected in 2013 using a nationally cross-sectional online survey of U.S. adults (cisgender, n = 17,164; transgender, n = 168) and analyzed in 2015. Past 30-day tobacco use point estimates and adjusted logistic regression while controlling for false discovery rate were reported for transgender and cisgender respondents.Results: Transgender adults reported higher past 30-day use of any cigarette/cigar/e-cigarette product (39.7% vs 25.1%) and current use of cigarettes (35.5% vs 20.7%), cigars (26.8% vs 9.3%), and e-cigarettes (21.3% vs 5.0%) compared with cisgender adults (all p-values r0.003). Transgender respondents had significantly higher odds of past 30-day tobacco product use for any cigarette/ cigar/e-cigarette product (OR = 1.97, 95% CI = 1.25, 3.1), e-cigarettes (OR = 5.15, 95% CI = 3.36, 7.88), cigars (OR = 3.56, 95% CI = 2.27, 5.59), and cigarettes (OR = 2.10, 95% CI = 1.35, 3.28) versus cisgender respondents (all p-values